Loss of heterozygosity of CDKN2A (p16INK4a) and RB1 tumor suppressor genes in testicular germ cell tumors
By: Tomislav Vladusic, Reno Hrascan, Nives Pecina-Slaus, Ivana Vrhovac, Marija Gamulin, Jasna Franekic and Bozo Kruslin
Open Access
|Aug 2010References
- Fombonne J, Devouassoux-Shisheboran M, Bouvier R, Droz J-P, Benahmed M, Krantic S. Analysis of p16INK4A gene promoter in male germ-cell tumors: identification of a new point mutation.2005;: 1-7.
- Kachanov DY, Dobrenkov KV, Shamanskaya TV, Abdullaev RT, Inushkina EV, Savkova RF. Solid tumors in young children in Moscow Region of Russian Federation.2008;: 39-44.
- Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Tumours of the testis and paratesticular tissue. In: Kleihues P, Sobin LH, editors.Lyon: IARC Press; 2004. p. 217-78.
- Bergthorsson JT, Agnarsson BA, Gudbjartsson T, Magnusson K, Thoroddsen A, Palsson B, et al. A genome-wide study of allelic imbalance in human testicular germ cell tumors using microsatellite markers.2006;: 1-9.
- von Eyben FE. Chromosomes, genes, and development of testicular germ cell tumors.2004;: 93-138.
- Bartek J, Bartkova J, Lukas J. The retinoblastoma protein pathway in cell cycle control and cancer.1997;: 1-6.
- Bartkova J, Rajpert-De Meyts E, Skakkebæk NE, Lukas J, Bartek J. Deregulation of the G1/S-phase control in human testicular germ cell tumours.2003;: 252-66.
- Adams PD, Li X, Sellers WR, Baher KB, Leng X, Harper JW, et al. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complex.1999;: 1068-80.
- Parry D, Mahony D, Willis K, Lees E. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.1999;: 1775-83.
- Sherr CJ. Cancer cell cycles.1996;: 1672-77.
- Zhang HS, Postigo AA, Dean DC., Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFβ, and contact inhibition.1999;: 53-61.
- Bartkova J, Lukas C, Sørensen CS, Rajpert-De Meyts E, Skakkebæk NE, Lukas J, et al. Deregulation of the RB pathway in human testicular germ cell tumours.2003;: 149-56.
- Schmidt BA, Rose A, Steinhoff C, Strohmeyer T, Hartman M, Ackermann R. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.2001;: 4214-21.
- Herranz M, Urioste M, Santos J, Rivas C, Martinez B, Benitez J, et al. Analysis of the INK4a/ARF locus in non-Hodkin's lymphomas using two new internal microsatellite markers.1999;: 808-10.
- Xing EP, Yang G-Y, Wang L-D, Shi ST, Yang CS. Loss of heterozygosity of thegene correlates with pRb protein expression and associates withalteration in human esophageal cancer.1999;: 1231-40.
- Jones PA, Laird PW. Cancer epigenetics comes of age.1999;: 163-67.
- Honorio S, Agathanggelou A, Wernert N, Rothe M, Maher ER, Latif F. Frequent epigenetic inactivation of thetumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.2003;: 461-66.
- Chaubert P, Guillou L, Kurt A-M, Bertholet M-M, Metthez G, Leisinger H-J. Frequentgene inactivation in testicular germ cell tumors.1997;: 859-65.
- Heidenreich A, Gaddipati JP, Moul JW, Srivastava S. Molecular analysis of P16/CDKN2 and P15/MTS2 genes in primary human testicular germ cell tumors.1998;: 1725-30.
- Faulkner SW, Leigh DA, Oosterhuis JW, Roelofs H, Looijenga LHJ, Friedlander ML. Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model.2000;: 729-36.
- Vladušić T, Hrašćan R, Vrhovac I, Krušlin B, Gamulin M, Grgić M, et al. Loss of heterozygosity of selected tumor suppressor genes in human testicular germ cell tumors.2010;: 163-7.
- Jones RH, Vasey PA. New directions in testicular cancer; molecular determinants of oncogenesis and treatment success.2003;: 147-56.
- Strohmeyer T, Reissmann P, Cordon-Cardo C, Hartmann M, Ackermann R, Slamon D. Correlation between retinoblastoma gene expression and differentiation in human testicular tumors.1991;: 6662-6.
- Peng H-Q, Bailey D, Bronson D, Goss PE, Hogg D. Loss of heterozygosity of tumor suppressor genes in testis cancer.1995;: 2871-75.
- Rothe M, Albers P, Wernert N. Loss of heterozygosity, differentiation, and clonality in microdissected male germ cell tumours.1999;: 389-94.
- Heidenreich A, Sesterhenn IA, Mostof FK, Moul JW. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.1998;: 1002-11.
- Bartkova J, Falck J, Rajpert-De Meyts E, Skakkebæk NE, Lukas J, Bartek J. Chk2 tumor suppressor protein in human spermatogenesis and testicular germ-cell tumours.2001;: 5897-902.
- Kamensek U, Sersa G. Targeted gene therapy in radiotherapy.2008;: 115-35.
Language: English
Page range: 168 - 173
Published on: Aug 9, 2010
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2010 Tomislav Vladusic, Reno Hrascan, Nives Pecina-Slaus, Ivana Vrhovac, Marija Gamulin, Jasna Franekic, Bozo Kruslin, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.